Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -838,094 | -509,383 | -49,976 | -20,443 | -335,534 |
| Depreciation Amortization | 37,541 | 23,726 | 14,932 | 6,555 | 245,980 |
| Income taxes - deferred | 78,248 | 143,000 | N/A | N/A | 59,260 |
| Other Working Capital | -15,453 | -97,892 | -1,828 | 27,174 | -173,311 |
| Loans | -957 | -12,382 | -11,012 | -10,021 | 0 |
| Other Operating Activity | 975,748 | 642,883 | 211,516 | 91,018 | 360,622 |
| Operating Cash Flow | $237,033 | $189,952 | $163,632 | $94,283 | $157,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,124 | -10,719 | -6,037 | -3,674 | -14,004 |
| Purchase Of Investment | -1,545,533 | -1,511,022 | -1,218,048 | -559,468 | -2,228,300 |
| Sale Of Investment | 2,234,268 | 1,740,767 | 1,340,187 | 480,470 | 1,392,185 |
| Net Loans | 504,180 | 282,738 | 16,904 | -37,312 | -331,173 |
| Other Investing Activity | 95,914 | 59,691 | 33,437 | 11,288 | 11,635 |
| Investing Cash Flow | $1,273,705 | $561,455 | $166,443 | $-108,696 | $-1,169,657 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -113,877 | -70,055 | -66,893 | 59,139 | -15,822 |
| Debt Issued | 220,000 | 90,500 | 121,000 | 85,000 | 781,906 |
| Debt Repayment | -608,930 | -380,885 | -345,840 | -237,794 | -742,733 |
| Common Stock Issued | N/A | 0 | N/A | N/A | 304,390 |
| Dividend Paid | -6,733 | -6,733 | -6,733 | -2,946 | -20,487 |
| Other Financing Activity | 0 | 1,484 | 327 | 1,190 | -22,925 |
| Financing Cash Flow | $-1,084,757 | $-438,989 | $-344,805 | $42,216 | $956,964 |
| Beginning Cash Position | 138,802 | 138,802 | 138,802 | 138,802 | 194,478 |
| End Cash Position | 564,783 | 451,220 | 124,072 | 166,605 | 138,802 |
| Net Cash Flow | $425,981 | $312,418 | $-14,730 | $27,803 | $-55,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | 237,033 | 189,952 | 163,632 | 94,283 | 157,017 |
| Capital Expenditure | -15,124 | -10,746 | -6,099 | -3,681 | -13,980 |
| Free Cash Flow | 221,909 | 179,206 | 157,533 | 90,602 | 143,037 |